NEUROTERA project funded

16 August, 2016

Large logo neurotera1

BSIM Therapeutics has secured support for its NEUROTERA project by COMPETE 2020 of PT2020, through the European Regional Development Fund.


This project aims at exploiting our potent TTR amyloid inhibitors, by targeting selected drug candidates to the eye and the brain, for the treatment of the clinical manifestations linked with those organs.

By continuing to browse the site, you expressly agree that cookies will be stored on your computer to help measure statistics of visits and improve the quality of the contents offered.Learn more